// App-Quantinova.ai

O-283 : Evidence based management of endometriosis – what has changed since 2013?

Researchers

Presenter

  • C Becker

Principal Investigators

  • A Bokor

  • O Heikinheimo

  • A Horne

  • F Jansen

  • L Kiesel

  • K King

  • M Kvaskoff

  • A Nap

  • K Petersen

  • E Saridogan

  • C Tomassetti

  • N Van Hanegem

  • N Vulliemoz

  • N Vermeulen

Medical Centers

  • University of Oxford, Nuffield Department of Women’s and Reproductive Health, Oxford, United Kingdom

  • Semmelweis University, II. Department of Obstetrics and Gynecology, Budapest, Hungary

  • EndoHome, Endometriosis Association Belgium, Eksel, Belgium

  • Universirty College London Hospitals, Elizabeth Garrett Anderson Institute for Women’s Health, London, United Kingdom

  • University Hospital Ulm, Department of Gynecology and Obstetrics, Ulm, Germany

  • University Hospitals Leuven, Dept. Obstetrics and Gynaecology- Leuven University Fertility Center, Leuven, Belgium

  • Paris-Saclay University- UVSQ- Univ. Paris-Sud- Inserm- Gustave Roussy, “Exposome and Heredity” team- CESP, Paris, France

  • Lausanne University Hospital, Fertility Medicine and Gynaecological Endocrinology- Department Woman Mother Child, Lausanne, Switzerland

  • University of Edinburgh, EXPPECT Centre for Endometriosis and Pelvic Pain- MRC Centre for Reproductive Health, Edinburgh, United Kingdom

  • Individual Endometriosis Advocate, Private, Dublin, Ireland

  • Radboudumc, Department of Gynaecology and Obstetrics, Nijmegen, The Netherlands

  • University College London Hospitals, Pain Management Centre, London, United Kingdom

  • University Medical Center Utrecht, Obstetrics and Gynaecology, Utrecht, Netherlands

  • European Society of Human Reproduction and Embryology, Central Office, Strombeek-Bever, Belgium

Locations

  • United Kingdom

  • Hungary

  • Belgium

  • Germany

  • Finland

  • France

  • Switzerland

  • Ireland

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

  • Obstetrics/Gynecology

  • Genetic Disorder

Disease

  • Gynaecological cancer

  • Thyroid Cancer

  • Endometriosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved